Cargando…
Molecular alterations of driver genes in non-small cell lung cancer: from diagnostics to targeted therapy
Lung cancer is the leading cause of cancer death all over the world. The majority (80-85 %) of lung cancer cases are classified as non-small cell lung cancer (NSCLC). Within NSCLC, adenocarcinoma (AC) and squamous cell carcinoma (SCC) are the most often recognized. The histological and immunohistoch...
Autores principales: | Grodzka, Anna, Knopik-Skrocka, Agnieszka, Kowalska, Katarzyna, Kurzawa, Pawel, Krzyzaniak, Monika, Stencel, Katarzyna, Bryl, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279966/ https://www.ncbi.nlm.nih.gov/pubmed/37346803 http://dx.doi.org/10.17179/excli2023-6122 |
Ejemplares similares
-
Cancer Stem Cells—The Insight into Non-Coding RNAs
por: Bryl, Rut, et al.
Publicado: (2022) -
Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma
por: Rybarczyk-Kasiuchnicz, Agnieszka, et al.
Publicado: (2021) -
Neoadjuvant and Adjuvant Immunotherapy in Non-Small Cell Lung Cancer—Clinical Trials Experience
por: Chmielewska, Izabela, et al.
Publicado: (2021) -
Anti-angiogenic agents in the treatment of non-small cell lung cancer
por: Szyszka-Barth, Katarzyna, et al.
Publicado: (2014) -
Peripheral T-Cell Lymphoma Possibly Due to Unrecognized Celiac Disease in an Elderly Patient: A Case Report
por: Braszak-Cymerman, Anna, et al.
Publicado: (2021)